202 related articles for article (PubMed ID: 17275887)
41. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
Cantero M; Rojas H; Anglés-Cano E; Marchi R
BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
[TBL] [Abstract][Full Text] [Related]
42. Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF-κB dependent.
Owens S; Jeffers A; Boren J; Tsukasaki Y; Koenig K; Ikebe M; Idell S; Tucker TA
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1265-73. PubMed ID: 25888576
[TBL] [Abstract][Full Text] [Related]
43. Hybrid molecules: insights into plasminogen activator function.
Runge MS; Bode C; Haber E; Quertermous T
Mol Biol Med; 1991 Apr; 8(2):245-55. PubMed ID: 1806766
[TBL] [Abstract][Full Text] [Related]
44. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
Bode C; Runge M; Eberle T; Freitag M; Kübler W; Haber E
Trans Assoc Am Physicians; 1989; 102():7-12. PubMed ID: 2517856
[No Abstract] [Full Text] [Related]
45. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
[TBL] [Abstract][Full Text] [Related]
46. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
47. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
48. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
49. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
50. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
51. Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury.
Tucker T; Idell S
Semin Thromb Hemost; 2013 Jun; 39(4):373-81. PubMed ID: 23504608
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
53. [Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells].
Min R; Li S; Wang H; Zhang J; Wang T; Yang Y
Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):599-602. PubMed ID: 11798526
[TBL] [Abstract][Full Text] [Related]
54. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin.
Braat EA; Los P; Rijken DC
Blood Coagul Fibrinolysis; 1998 Jul; 9(5):419-27. PubMed ID: 9712290
[TBL] [Abstract][Full Text] [Related]
55. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
56. Activation of single-chain urokinase-type plasminogen activator by a hemorrhagic metalloproteinase, jararafibrase I, in Bothrops jararaca venom.
Sugiki M; Yoshida E; Anai K; Maruyama M
Toxicon; 1998 Jul; 36(7):993-1000. PubMed ID: 9690792
[TBL] [Abstract][Full Text] [Related]
57. Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.
Wilson HM; Reid FJ; Brown PA; Power DA; Haites NE; Booth NA
Exp Nephrol; 1993; 1(6):343-50. PubMed ID: 8081986
[TBL] [Abstract][Full Text] [Related]
58. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.
Hertig A; Berrou J; Allory Y; Breton L; Commo F; Costa De Beauregard MA; Carmeliet P; Rondeau E
FASEB J; 2003 Oct; 17(13):1904-6. PubMed ID: 12897066
[TBL] [Abstract][Full Text] [Related]
59. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
60. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model.
Molinari A; Giorgetti C; Lansen J; Vaghi F; Orsini G; Faioni EM; Mannucci PM
Thromb Haemost; 1992 Feb; 67(2):226-32. PubMed ID: 1320301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
